rly-4008
relay therapeutics,delcath systems
['bcsm', 'focus trial', 'refocus']
helpful comparison of fly-4008 refocus trial with current landscape of fgfr2 inhibitors in cca (acknowledging limitations of cross-trial comparisons) by discussant rr promising toxicities
awaiting expanded cohort efficacy - pfs, os #hpbcsm #esmo22 
Cancer Doctor, Professor, Lifelong Learner #GI #Cancer ???? @UBC @BCCancer @CCTG #Prez @CAMO #TEDxSpeaker #MedTwitter Tweets are my own